{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:36:58Z","timestamp":1775587018283,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00210-025-04223-7","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:30:10Z","timestamp":1746430210000},"page":"15391-15398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of sacubitril\/valsartan on adverse clinical events in heart failure with end-stage renal disease patients\u2014a real life nationwide investigation"],"prefix":"10.1007","volume":"398","author":[{"given":"Wei-Syun","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"7","key":"4223_CR1","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2215\/CJN.14180920","volume":"16","author":"D Banerjee","year":"2021","unstructured":"Banerjee D, Rosano G, Herzog CA (2021) Management of heart failure patient with CKD. Clin J Am Soc Nephrol 16(7):1131\u20131139","journal-title":"Clin J Am Soc Nephrol"},{"key":"4223_CR2","unstructured":"Database NHIR (2015) Taiwan, http:\/\/nhird.nhri.org.tw\/en\/index.html (cited in 2015)"},{"issue":"1","key":"4223_CR3","doi-asserted-by":"publisher","first-page":"2222841","DOI":"10.1080\/0886022X.2023.2222841","volume":"45","author":"Y Ding","year":"2023","unstructured":"Ding Y, Wan L, Zhang ZC, Yang QH, Ding JX, Qu Z, Yu F (2023) Effects of sacubitril-valsartan in patients undergoing maintenance dialysis. Ren Fail 45(1):2222841","journal-title":"Ren Fail"},{"key":"4223_CR4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","volume":"50","author":"G Fonarow","year":"2007","unstructured":"Fonarow G, Stough W, Abraham W et al (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 50:768\u2013777","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4223_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.5551\/jat.48835","volume":"26","author":"WS Hu","year":"2019","unstructured":"Hu WS, Lin CL (2019) Risk of atrial fibrillation in patients with congenital heart disease: results of a propensity score-matched, nationwide cohort study. J Atheroscler Thromb 26(7):670\u2013677","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"4223_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ehf2.12659","volume":"7","author":"S Lee","year":"2020","unstructured":"Lee S, Oh J, Kim H, Ha J, Chun K-H, Lee CJ, Park S, Lee S-H, Kang S-M (2020) Sacubitril\/valsartan in patients with heart failure with reduced ejection fraction with end-stage of renal disease. ESC Heart Fail. 7(3):1125\u20131129","journal-title":"ESC Heart Fail."},{"issue":"2","key":"4223_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/cpt.3315","volume":"116","author":"WY Lin","year":"2024","unstructured":"Lin WY, Shao YHJ, Chiang AF, Huang CC, Chiang KF, Chan CS, Huang CY, Hsiao BY (2024) Long-term outcomes of sacubitril\/valsartan in heart failure with reduced ejection fraction and coexisting end-stage renal disease. Clin Pharmacol Ther 116(2):471\u2013477","journal-title":"Clin Pharmacol Ther"},{"issue":"36","key":"4223_CR8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund KA, ESC Scientific Document Group (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 42(36):3599\u20133726","journal-title":"Eur Heart J."},{"key":"4223_CR9","unstructured":"Parsons LS (2004) Performing a 1:N Case-control match on propensity score. Proceedings of the 29th SAS Users Group International Conference. Montr\u00e9al, Canada"},{"key":"4223_CR10","doi-asserted-by":"publisher","first-page":"937398","DOI":"10.1155\/2014\/937398","volume":"2014","author":"L Segall","year":"2014","unstructured":"Segall L, Nistor I, Covic A (2014) Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int 2014:937398","journal-title":"Biomed Res Int"},{"issue":"1","key":"4223_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10557-023-07481-w","volume":"39","author":"L Spatola","year":"2025","unstructured":"Spatola L, Zeiler M, Granata A (2025) Sacubitril\/valsartan in dialysis patients: update on current perspectives. Cardiovasc Drugs Ther 39(1):187\u2013193","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"4223_CR12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"TM Maddox","year":"2021","unstructured":"Writing Committee, Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Lindenfeld J, Masoudi FA, Motiwala SR, Oliveros E, Patterson JH, Walsh MN, Wasserman A, Yancy CW, Youmans QR (2021) 2021 update to the 2017 acc expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 77(6):772\u2013810","journal-title":"J Am Coll Cardiol"},{"key":"4223_CR13","first-page":"e240","volume":"128","author":"C Yancy","year":"2013","unstructured":"Yancy C, Jessup M, Bozkurt B (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation 128:e240\u2013e327","journal-title":"Circulation"},{"issue":"1","key":"4223_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11255-023-03599-w","volume":"56","author":"W Zhou","year":"2024","unstructured":"Zhou W, Yang X, Jin J, Cheng M, Li Y, Bai Y, Xu J (2024) The efficacy and safety of sacubitril\/valsartan in chronic kidney disease: a systematic review and meta-analysis. Meta-Analysis Int Urol Nephrol 56(1):181\u2013190","journal-title":"Meta-Analysis Int Urol Nephrol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04223-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04223-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04223-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:12:40Z","timestamp":1761304360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04223-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4223"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04223-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Research Ethics Committee at China Medical University Hospital CMUH110-REC1-038(CR-1)).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}